8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Pooled results from many studies on one question.
2015 / Meta-analysis of prospective cohorts
A meta-analysis of 14 prospective cohort studies comprising 1,903,459 participants and 12,261 cases evaluated dietary legume intake and colorectal cancer risk. Higher legume consumption was associated with reduced risk (RR 0.91, 95% CI 0.84-0.98), with inverse associations observed in Asian cohorts (RR 0.82, 95% CI 0.74-0.91) and for soybean consumption (RR 0.85, 95% CI 0.73-0.99).
Shows an association, not proof of cause and effect.
Zhu B, Sun Y, Qi L, et al. Sci Rep, 2015. PMID 25739376
2015 / Two systematic reviews and product composition analysis
Researchers conducted two systematic reviews evaluating the effectiveness and safety of pomegranate products for cancer treatment, alongside product compositional analyses. Four clinical studies investigating three pomegranate products were identified, with one study considered inappropriate due to low polyphenol content. The evidence of clinical effectiveness was poor because study quality was poor. While the doses used in clinical studies showed no safety concerns, pomegranate preparations may induce synthetic drug metabolism through liver enzyme activation.
Vlachojannis C, Zimmermann BF, Chrubasik-Hausmann S Evid Based Complement Alternat Med, 2015. PMID 25815026
2015 / Pooled analysis of prospective cohorts
Data from 6 prospective cohort studies totaling 661,137 men and women were pooled to evaluate the dose-response relationship between leisure time physical activity and mortality over a median follow-up of 14.2 years. Compared with no activity, mortality risk was lower among those performing less than the recommended minimum of 7.5 MET-hours/week (HR 0.80), 1 to 2 times the minimum (HR 0.69), and 2 to 3 times the minimum (HR 0.63). An upper threshold of benefit was seen at 3 to 5 times the recommended minimum (HR 0.61), with no evidence of harm observed at 10 or more times the minimum (HR 0.69). Similar dose-response associations were found for cardiovascular disease and cancer mortality.
Shows an association, not proof of cause and effect.
Arem H, Moore SC, Patel A, et al. JAMA Intern Med, 2015. PMID 25844730
2015 / Systematic review and meta-analysis of case-control studies
A systematic review and meta-analysis investigated the relationship between fried food intake and prostate cancer risk across four case-control studies. The analysis included 2,579 cancer patients and 2,277 matched controls. Greater intake of fried food was associated with a 35% higher risk of prostate cancer (95% CI: 17% to 57%).
Shows an association, not proof of cause and effect.
Lippi G, Mattiuzzi C Int J Food Sci Nutr, 2015. PMID 26114920
2015 / Dose-response meta-analysis of prospective cohort studies
A dose-response meta-analysis of 18 prospective cohort studies examined tea intake and cause-specific mortality. Green tea consumption was inversely associated with cardiovascular mortality (highest vs. lowest RR 0.67; 95% CI: 0.46, 0.96) and all-cause mortality (RR 0.80; 95% CI: 0.68, 0.93). Black tea was inversely associated with cancer mortality (RR 0.79; 95% CI: 0.65, 0.97) and all-cause mortality (RR 0.90; 95% CI: 0.83, 0.98).
Shows an association, not proof of cause and effect.
Tang J, Zheng JS, Fang L, et al. Br J Nutr, 2015. PMID 26202661
2015 / Dose-response meta-analysis of prospective observational studies
A dose-response meta-analysis of prospective studies investigated egg intake and sex hormone-related cancers. Consuming at least 5 eggs per week was linked to increased breast cancer risk compared to no intake (RR 1.04; 95% CI: 1.01, 1.07 for 5 eggs/week; RR 1.09; 95% CI: 1.03, 1.15 for 9 eggs/week). An increase of 5 eggs weekly was also associated with fatal prostate cancer (RR 1.47; 95% CI: 1.01, 2.14), but not total prostate cancer.
Shows an association, not proof of cause and effect.
Keum N, Lee DH, Marchand N, et al. Br J Nutr, 2015. PMID 26293984
2015 / Meta-analysis of prospective cohorts
A meta-analysis of 16 prospective cohort studies including 2,020,641 participants examined night-shift work in relation to health outcomes. An increase in night-shift work was associated with incident breast cancer (RR 1.057, 95% CI 1.014-1.102) and cardiovascular death (RR 1.027, 95% CI 1.001-1.053). Longer duration showed higher breast cancer associations, reaching an RR of 1.088 (95% CI 1.012-1.169) for over 20 years, whereas all-cause death was not significantly associated (RR 1.253, 95% CI 0.786-1.997).
Shows an association, not proof of cause and effect.
Lin X, Chen W, Wei F, et al. Sleep Med, 2015. PMID 26498240
2014 / Systematic review of clinical trials and observational studies
A systematic review examined 10 studies evaluating flaxseed and breast cancer. In randomized trials of newly diagnosed patients, 25 g daily of flax increased apoptotic index and reduced HER2 expression (both P < 0.05) relative to control. Observational investigations linked flax intake to lower primary breast cancer incidence (OR = 0.82; 95% CI: 0.69-0.97) and lower mortality (HR = 0.69; 95% CI: 0.50-0.95).
Flower G, Fritz H, Balneaves LG, et al. Integr Cancer Ther, 2014. PMID 24013641
2014 / Systematic review
A systematic review examined studies investigating the association of coffee consumption with liver-related laboratory tests, viral hepatitis, NAFLD, cirrhosis, and hepatocellular carcinoma (HCC). In people at risk for liver disease, coffee intake was dose-dependently associated with improved serum GGT, AST, and ALT values. In patients with chronic liver disease, coffee consumption was linked to a lower risk of progression to cirrhosis, reduced mortality in cirrhosis, and lower HCC development. Coffee was also linked to improved virologic responses in chronic hepatitis C and was inversely related to steatohepatitis severity in NAFLD.
Shows an association, not proof of cause and effect.
Saab S, Mallam D, Cox GA, et al. Liver Int, 2014. PMID 24102757
2014 / Systematic review and meta-analysis of epidemiological studies
A systematic review and meta-analysis of 59 epidemiological studies assessed iron intakes, body stores, and cancer risk. Each additional 1 mg per day of heme iron was associated with colorectal cancer (RR = 1.08; 95% CI: 1.00-1.17) and colon cancer (RR = 1.12; 95% CI: 1.03-1.22), with weaker links to breast and lung cancer. Biomarkers reflecting iron stores showed an inverse pattern with cancer risk.
Shows an association, not proof of cause and effect.
Fonseca-Nunes A, Jakszyn P, Agudo A Cancer Epidemiol Biomarkers Prev, 2014. PMID 24243555
2014 / Meta-analysis of observational studies
A meta-analysis of 15 case-control and two cohort studies evaluated personal hair dye use and bladder cancer incidence/mortality. Compared with no use, the pooled relative risk (RR) for personal use of any hair dye was 0.93 (95% CI, 0.82-1.05), with similar RRs for females (RR = 0.95) and males (RR = 0.81). Personal use of permanent hair dyes also showed no association (RR = 0.92; 95% CI, 0.77-1.09), and no association was seen for the highest categories of duration or lifetime frequency of use. Use of dark-colored dyes yielded a pooled RR of 1.29 (95% CI, 0.98-1.71).
Shows an association, not proof of cause and effect.
Turati F, Pelucchi C, Galeone C, et al. Ann Epidemiol, 2014. PMID 24342029
2014 / Systematic review and meta-analysis of randomized trials
Across 56 randomized trials with 95,286 participants, supplemental vitamin D decreased all-cause mortality (RR 0.97; 95% CI 0.94 to 0.99; P = 0.02). When examined by specific compound, only cholecalciferol yielded a significant reduction in mortality (RR 0.94; 95% CI 0.91 to 0.98; 38 trials), whereas ergocalciferol and active forms showed no significant mortality benefit. Vitamin D3 also lowered cancer mortality (RR 0.88; 95% CI 0.78 to 0.98), but combined use with calcium raised nephrolithiasis risk.
Bjelakovic G, Gluud LL, Nikolova D, et al. Cochrane Database Syst Rev, 2014. PMID 24414552
2014 / Meta-analysis of prospective cohort studies
In an updated meta-analysis encompassing 4,172,412 individuals, researchers evaluated how Mediterranean diet adherence related to clinical outcomes. A two-point increase in adherence score was linked to an 8% lower risk of all-cause mortality (RR 0.92, 95% CI 0.91 to 0.93). It was also linked to a 10% lower cardiovascular disease risk (RR 0.90, 95% CI 0.87 to 0.92) and a 4% lower risk of neoplastic disease (RR 0.96, 95% CI 0.95 to 0.97).
Shows an association, not proof of cause and effect.
NANO counterpoint →
Sofi F, Macchi C, Abbate R, et al. Public Health Nutr, 2014. PMID 24476641
2014 / Meta-analysis of case-control and cohort studies
A meta-analysis of 37 case-control and seven cohort studies, including 424,867 participants and 18,852 GI neoplasm cases, assessed egg intake. Highest versus lowest egg consumption was associated with a slight increase in GI neoplasm risk (OR 1.15; 95% CI: 1.09-1.22), with a stronger link for colon cancer (OR 1.29; 95% CI: 1.14-1.46). Dose-response analyses also showed modest risk increases across categories of weekly egg consumption.
Shows an association, not proof of cause and effect.
Tse G, Eslick GD Eur J Nutr, 2014. PMID 24500371
2014 / Meta-analysis of cohort and case-control studies
A meta-analysis of 13 studies investigated the association between egg consumption and breast cancer. Overall, egg consumption was associated with higher breast cancer risk (RR 1.04, 95% CI 1.01-1.08). The association remained significant in cohort studies (RR 1.04, 95% CI 1.00-1.08), European and Asian populations, postmenopausal women, and among individuals consuming 2 to 5 eggs weekly, but not in case-control studies.
Shows an association, not proof of cause and effect.
Si R, Qu K, Jiang Z, et al. Breast Cancer, 2014. PMID 24504557
2014 / Meta-analysis
A meta-analysis of 21 published studies assessed the link between tea intake and prostate cancer risk. Overall comparison of highest versus lowest consumption found no statistically significant association (OR 0.86, 95% CI 0.69-1.04). Subgroup analyses by tea type and population were also nonsignificant, though case-control studies showed a borderline inverse association (OR 0.77, 95% CI 0.55-0.98).
Lin YW, Hu ZH, Wang X, et al. World J Surg Oncol, 2014. PMID 24528523
2014 / Meta-analysis of prospective cohort studies
A meta-analysis of prospective cohort studies examined 2,330 colorectal cancer patients and 4,413 breast cancer patients across ten studies. Comparing highest to lowest 25-hydroxyvitamin D categories, pooled hazard ratios were 0.71 (95% CI 0.55-0.91) for overall mortality and 0.65 (95% CI 0.49-0.86) for disease-specific mortality in colorectal cancer. In breast cancer, corresponding hazard ratios were 0.62 (95% CI 0.49-0.78) and 0.58 (95% CI 0.38-0.84).
Shows an association, not proof of cause and effect.
Maalmi H, Ordóñez-Mena JM, Schöttker B, et al. Eur J Cancer, 2014. PMID 24582912
2014 / Systematic review and meta-analysis of observational studies
Researchers meta-analyzed 21 cohort studies (1,368,736 subjects) and 12 case-control studies (62,725 subjects) evaluating Mediterranean diet adherence and cancer risk. The highest adherence category was associated with a significant risk reduction for overall cancer mortality/incidence in cohort studies (RR: 0.90, 95% CI 0.86-0.95), colorectal cancer (RR: 0.86, 95% CI 0.80-0.93), prostate cancer (RR: 0.96, 95% CI 0.92-0.99), and aerodigestive cancer (RR: 0.44, 95% CI 0.26-0.77). Nonsignificant changes were observed for breast, gastric, and pancreatic cancers. Limited evidence of substantial publication bias was observed.
Shows an association, not proof of cause and effect.
NANO counterpoint →
Schwingshackl L, Hoffmann G Int J Cancer, 2014. PMID 24599882
2014 / Meta-analysis of RCTs and a prospective cohort study
Investigators conducted a meta-analysis of two randomized controlled trials and one large multicenter prospective cohort study involving 9,966 breast cancer patients. A post-diagnostic low-fat diet reduced the risk of breast cancer recurrence by 23% (HR=0.77, 95% CI 0.63 to 0.94, P=0.009) and all-cause mortality by 17% (HR=0.83, 95% CI 0.69 to 1.00, P=0.05). The authors concluded that a low-fat diet can improve breast cancer survival by reducing recurrence risk, though more trials are needed regarding all-cause mortality.
Shows an association, not proof of cause and effect.
Xing MY, Xu SZ, Shen P Asian Pac J Cancer Prev, 2014. PMID 24606431
2014 / Systematic review and meta-analysis of cohort studies and randomized controlled trials
In an analysis of 73 observational cohorts with 849,412 adults, lowest versus highest circulating 25-hydroxyvitamin D was associated with higher cardiovascular mortality (RR 1.35; 95% CI: 1.13-1.61) and all-cause mortality (RR 1.35; 95% CI: 1.22-1.49). Across 22 randomized trials with 30,716 participants, vitamin D3 supplementation reduced all-cause mortality (RR 0.89; 95% CI: 0.80-0.99), whereas vitamin D2 did not show a clear benefit (RR 1.04; 95% CI: 0.97-1.11).
Chowdhury R, Kunutsor S, Vitezova A, et al. BMJ, 2014. PMID 24690623
2014 / Systematic review and meta-analysis
A meta-analysis of 25 studies involving 17,332 cancer cases assessed associations between circulating 25(OH)D levels at or near diagnosis and patient outcomes. Comparing the highest to lowest quartiles, pooled hazard ratios for overall survival were 0.55 (95% CI = 0.33-0.91) for colorectal cancer, 0.63 (95% CI = 0.51-0.77) for breast cancer, and 0.48 (95% CI = 0.36-0.64) for lymphoma. Higher 25(OH)D levels were also significantly associated with reduced cancer-specific mortality for colorectal cancer (P = .005) and lymphoma (P < .001), as well as improved disease-free survival for breast cancer (P < .001) or lymphoma (P < .05). A 10-nmol/L increment in circulating 25(OH)D was associated with a hazard ratio of 0.96 (95% CI = 0.95-0.97) for overall survival.
Shows an association, not proof of cause and effect.
Li M, Chen P, Li J, et al. J Clin Endocrinol Metab, 2014. PMID 24780061
2014 / Meta-analysis of randomized controlled trials
A meta-analysis evaluated randomized controlled trials of vitamin D supplementation spanning 2 to 7 years. Supplementation at doses of 400 to 1,100 IU daily did not affect total cancer incidence across four trials with 4,333 cases (summary RR 1.00, 95% CI, 0.94 to 1.06). However, doses of 400 to 833 IU daily significantly reduced cancer mortality across three trials with 1,190 deaths (summary RR 0.88, 95% CI, 0.78 to 0.98).
Keum N, Giovannucci E Br J Cancer, 2014. PMID 24918818
2014 / Systematic review
A systematic review evaluated evidence from 1990 to 2013 on potential chemopreventive nutrients in prostate cancer. Results indicated that red meat, dietary fat, and milk intake appear to increase prostate cancer risk, whereas fruits, vegetables, and polyphenols may have preventive roles. Selenium and vitamin supplements cannot be advocated for prevention, and higher doses may be linked to a worse prognosis. No specific evidence of benefits was found for prebiotics or probiotics.
Shows an association, not proof of cause and effect.
Mandair D, Rossi RE, Pericleous M, et al. Nutr Metab (Lond), 2014. PMID 24976856
2014 / Prospective cohort study
In a prospective study of 1,598 patients with stage I to III colorectal cancer, postoperative plasma 25-hydroxyvitamin D concentrations were measured alongside vitamin D receptor genotypes. Comparing the highest to lowest tertile, higher vitamin D levels were associated with lower colorectal cancer mortality (adjusted HR 0.68, 95% CI, 0.50 to 0.90) and all-cause mortality (adjusted HR 0.70, 95% CI, 0.55 to 0.89). Significant interactions were also observed between 25-hydroxyvitamin D levels and vitamin D receptor genetic variants.
Shows an association, not proof of cause and effect.
Zgaga L, Theodoratou E, Farrington SM, et al. J Clin Oncol, 2014. PMID 25002714